Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2019-11-07 Major Shareholding Noti…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is used to report changes in share ownership by major shareholders or insiders, which corresponds to the 'Major Shareholding Notification' category in the provided schema.
2019-11-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by a specific entity (Bucket Studio) in a target company (BTOne), including the purpose of holding, contract details, and funding sources. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-11-07 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). This document outlines the issuance of new shares, the purpose of capital raising, and the third-party allocation details. In the context of financial filings, announcements regarding capital structure changes, such as share issuance or capital increases, are classified under 'Share Issue/Capital Change'.
2019-11-01 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 98% confidence The document is a formal regulatory disclosure regarding the acquisition of shares in another company (Vidente Co., Ltd.) by the issuer (BitOne). It details the acquisition amount, purpose, and financial status of the target company. This type of disclosure is a standard regulatory filing in the Korean market (DART system) regarding corporate investment activities, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually implies a merger or takeover bid) or Share Issue/Capital Change.
2019-11-01 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's CEO (Representative Director). It lists the outgoing and incoming individuals, the reason for the change, and the effective date. This falls directly under the definition of Board/Management Information (MANG).
2019-11-01 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (BTOne) detailing the adjustment of the conversion price for convertible bonds due to a decline in market price. This type of disclosure regarding changes to the terms of convertible securities (conversion price, exercise price, or exchange price) falls under capital structure changes and financing updates. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most accurate category for adjustments to convertible debt instruments.
2019-10-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.